Psychedelics are back baby! Their effects on the brain are poised to revolutionise modern medicine.
Mind-altering substances have a long history in ancient ceremonies and rituals, before being banned in the tumultuous and risk-taking 1960s. Now they are providing new therapeutic hope in the management of medical conditions such as mental illness and addiction.
Find out how these drugs work, who might benefit and what is involved to get them back on the right side of the law, including the first psilocybin clinical trial to be approved in Australia.
Margaret Ross is a Senior Clinical Psychologist at St. Vincent's Hospital Melbourne, working in the Psychosocial Cancer Care and Palliative Medicine Departments. She has worked as a research fellow at...View Profile
Olivia Carter is an Associate Professor at the University of Melbourne School of Psychological Sciences. She completed a PhD in neuroscience at The University of Queensland exploring the effects of...View Profile
Matthew W. Johnson, PhD, is a Professor at Johns Hopkins and an expert on psychedelics, other drugs, and addiction. He has conducted research in behavioural pharmacology including psychedelics for >20...View Profile
Paul Liknaitzky is a Research Fellow at Deakin University and Odyssey House Victoria. Paul has an Honours in Neuroscience and a PhD in Psychology from The University of Melbourne. His...View Profile
Natasha Mitchell is a multi-award winning radio host, science journalist, and podcaster with the Australian Broadcasting Corporation (ABC). She presents the weekly culture and science program, Science Friction, on ABC...View Profile
To discuss your access requirements and to book any access services for performances, please call Qtix 136246. Want to plan your QPAC visit? Learn More
Eligible For Bundle Discount
Buy 4 or more tickets to selected events and save 20%. Learn More
Send this to a friend